📰 Chat Date News
Chat Date News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Chat Date. Real-time updates on events, politics, business and more.
May 7, 2024
Biodesix, Inc. , a leading diagnostic solutions company with a focus in lung disease, announced today that Scott Hutton, Chief Executive Officer of Biodesix, will present and host in-person 1x1...
February 29, 2024
WESTLAKE VILLAGE, Calif., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology,
January 31, 2024
WESTLAKE VILLAGE, Calif., Jan. 31, 2024 -- Arcutis Biotherapeutics, Inc. , a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today...
November 7, 2023
ROCKVILLE, Md., Nov. 7, 2023 /PRNewswire/ -- REGENXBIO Inc. today announced it will participate the following upcoming investor conferences: Stifel 2023 Healthcare Conference Fireside Chat Date:...
September 5, 2023
/PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced it will participate in the following upcoming investor conferences: Morgan Stanley 21st Annual...
July 31, 2023
NORWOOD, Mass., July 31, 2023 /PRNewswire/ -- Corbus Pharmaceuticals Holdings, Inc. , a precision oncology company, today announced that Yuval Cohen, Ph.D., Chief Executive Officer of Corbus, will...
June 16, 2023
Vistagen , a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other central nervous system disorders,... | June 16, 2023
June 6, 2023
Vistagen , a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other central nervous system disorders,... | June 6, 2023
June 6, 2023
FinancialContent fully hosted finance channel
June 6, 2023
WESTLAKE VILLAGE, Calif., June 06, 2023 -- Arcutis Biotherapeutics, Inc. , an early-stage commercial company focused on developing meaningful innovations in immuno-dermatology, today announced... | June 10, 2023